0001415889-22-012348.txt : 20221209
0001415889-22-012348.hdr.sgml : 20221209
20221209172107
ACCESSION NUMBER: 0001415889-22-012348
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20221207
FILED AS OF DATE: 20221209
DATE AS OF CHANGE: 20221209
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Yu Hong
CENTRAL INDEX KEY: 0001743047
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35853
FILM NUMBER: 221455666
MAIL ADDRESS:
STREET 1: C/O BIOSTAGE, INC. 84 OCTOBER HILL ROAD
CITY: HOLLISTON
STATE: MA
ZIP: 01746
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Biostage, Inc.
CENTRAL INDEX KEY: 0001563665
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 455210462
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 84 OCTOBER HILL ROAD
STREET 2: SUITE 11
CITY: HOLLISTON
STATE: MA
ZIP: 01746
BUSINESS PHONE: (774) 233-7300
MAIL ADDRESS:
STREET 1: 84 OCTOBER HILL ROAD
STREET 2: SUITE 11
CITY: HOLLISTON
STATE: MA
ZIP: 01746
FORMER COMPANY:
FORMER CONFORMED NAME: Harvard Apparatus Regenerative Technology, Inc.
DATE OF NAME CHANGE: 20121204
4
1
form4-12092022_101241.xml
X0306
4
2022-12-07
0001563665
Biostage, Inc.
BSTG
0001743047
Yu Hong
C/O BIOSTAGE, INC.
84 OCTOBER HILL ROAD, SUITE 11
HOLLISTON
MA
01746
false
true
false
false
PRESIDENT
Common Stock
2022-12-07
4
X
0
300000
2
A
306135
I
The spouse of the reporting person
Common Stock
2022-12-07
4
S
0
83676
7.17
D
222459
I
The spouse of the reporting person
Common Stock
44520
D
Warrants (right to buy)
2
2022-12-07
4
X
0
300000
0
D
2017-12-27
2022-12-27
Common Stock
300000
0
I
The spouse of the reporting person
On December 7, 2022, the Spouse of the Reporting Person exercised a warrant to purchase 300,000 shares of common stock for $2 per share. The Spouse of the Reporting Person paid the exercise price on a cashless basis, resulting in Biostage's withholding of 83,676 shares to pay the exercise price based on the daily VWAP of $7.1706, and issuing the remaining 216,324 shares of common stock.
/s/ Chad Porter, Attorney-in-Fact
2022-12-09